QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 goodrx-launches-16month-subscription-for-hair-loss-treatment-with-virtual-care-and-home-delivery

The all-in-one solution includes a virtual consultation, clinically proven prescription medication, and discreet home delivery,...

 hy-vee-announces-through-its-partnership-with-goodrx-all-strengths-of-glp-1-medications-ozempic-and-wegovy-pens-are-now-available-via-goodrx-for-499-per-month

https://www.hy-vee.com/corporate/news-events/news-press-releases/hyvee-pharmacy-patients-can-now-purchase-ozempic--wegovy-at-a-...

 trump-administration-engages-pharmacies-goodrx-for-trumprx-launch

Pharmacies and GoodRx are in talks to join TrumpRx, a new drug pricing site aiming to lower prescription costs for U.S. consumers.

 goodrx-shares-resume-trade
GoodRx Shares Resume Trade
10/09/2025 16:34:36

 retail-pharmacies-goodrx-say-in-talks-with-trump-administration-on-trumprx-participation---reuters-exclusive

TrumpRx may expand beyond direct sales by drugmakersPharmacies seek role in TrumpRx for discount vouchersExperts say value of T...

Core News & Articles

The collaboration with Amgen reduces out-of-pocket costs for patients and expands access to an innovative cholesterol-lowering ...

 discounted-ozempic-could-deflate-etf-optimism-around-hims--hers

Hims & Hers investors hit with more bad news as Novo Nordisk partners with GoodRx to offer discounted access to competing p...

 whats-going-on-with-hims--hers-shares-today

Hims & Hers Health shares are trading lower Tuesday after GoodRx announces a collaboration with Novo Nordisk.

 ozempic-gains-first-approval-in-canada-for-kidney-disease-and-cardiovascular-death-risk

Health Canada approved Ozempic for type 2 diabetes patients with chronic kidney disease after positive FLOW trial results.

 goodrx-gdrx-stock-is-sliding-tuesday-whats-going-on

GoodRx shares are pulling back Tuesday morning. The stock had jumped over 30% Monday after the company announced a new partners...

 goodrx-holdings-surges-5-after-hours-on-novo-nordisk-partnership-for-499-monthly-ozempic-wegovy-access

GoodRx stock rose 5.08% after it partnered with Novo Nordisk to offer Ozempic and Wegovy at a flat $499 monthly price for self-...

 intel-palo-alto-networks-goodrx-applied-digital-and-duolingo-why-these-5-stocks-are-on-investors-radars-today

The stock market presented a mixed picture on Friday, with the S&P 500 and the Dow Jones Industrial Average indices closing...

 stocks-muted-ahead-trump-zelenskyy-meeting-first-solar-jumps-whats-moving-markets-monday

Investor risk sentiment paused at the start of the week, as markets awaited details expected to emerge later when President Don...

 ozempic-and-wegovy-now-available-through-goodrx-at-reduced-self-pay-price-stock-skyrockets

GoodRx and Novo Nordisk launch a $499 monthly self-pay option for Ozempic and Wegovy, expanding access at 70,000 pharmacies acr...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION